Akiko Iwasaki, Ph.D.

Position: Chief Preclinical Advisor and Co-founder

Dr. Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular, and Developmental Biology at Yale University, and an Investigator of the Howard Hughes Medical Institute. Her research focuses on the mechanisms of immune defense against viruses at mucosal surfaces, and the development of mucosal vaccine strategies. She is the co-Lead Investigator of the Yale COVID-19 Recovery Study, which aims to determine the changes in the immune response of people with long COVID after vaccination. Akiko also leads multiple other studies to interrogate the pathobiology of long COVID, both in patients, and through developing animal models of long COVID. Additionally, she was elected to the National Academy of Sciences in 2018, to the National Academy of Medicine in 2019, to the European Molecular Biology Organization in 2021, and to the American Academy of Arts and Sciences in 2021. Akiko received a Ph.D. from the University of Toronto in Canada and conducted her postdoctoral training at the National Institutes of Health.